×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
QNCX – quince therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
QNCX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
2/3
07:12 am
qncx
Quince Therapeutics (NASDAQ:QNCX) was downgraded by analysts at Maxim Group from a "strong-buy" rating to a "hold" rating.
High
Report
Quince Therapeutics (NASDAQ:QNCX) was downgraded by analysts at Maxim Group from a "strong-buy" rating to a "hold" rating.
1/31
07:46 am
qncx
Quince Therapeutics (NASDAQ:QNCX) was downgraded by analysts at Brookline Capital Management from a "strong-buy" rating to a "hold" rating.
High
Report
Quince Therapeutics (NASDAQ:QNCX) was downgraded by analysts at Brookline Capital Management from a "strong-buy" rating to a "hold" rating.
1/31
07:46 am
qncx
Quince Therapeutics (NASDAQ:QNCX) was downgraded by analysts at D Boral Capital from a "strong-buy" rating to a "hold" rating.
High
Report
Quince Therapeutics (NASDAQ:QNCX) was downgraded by analysts at D Boral Capital from a "strong-buy" rating to a "hold" rating.
1/31
07:46 am
qncx
Quince Therapeutics (NASDAQ:QNCX) was downgraded by analysts at Lucid Cap Mkts from a "strong-buy" rating to a "strong sell" rating.
High
Report
Quince Therapeutics (NASDAQ:QNCX) was downgraded by analysts at Lucid Cap Mkts from a "strong-buy" rating to a "strong sell" rating.
1/30
07:00 am
qncx
Quince Therapeutics (NASDAQ:QNCX) was downgraded by analysts at Citizens Jmp from an "outperform" rating to a "market perform" rating.
High
Report
Quince Therapeutics (NASDAQ:QNCX) was downgraded by analysts at Citizens Jmp from an "outperform" rating to a "market perform" rating.
1/29
10:01 pm
qncx
Quince Therapeutics (NASDAQ:QNCX) was downgraded by analysts at Citigroup Inc. from a "market outperform" rating to a "market perform" rating.
High
Report
Quince Therapeutics (NASDAQ:QNCX) was downgraded by analysts at Citigroup Inc. from a "market outperform" rating to a "market perform" rating.
1/12
11:40 am
qncx
Quince Therapeutics: Good Potential In Orphan Disease In Q1 With Platform Potential [Seeking Alpha]
High
Report
Quince Therapeutics: Good Potential In Orphan Disease In Q1 With Platform Potential [Seeking Alpha]
1/6
08:02 am
qncx
Quince Therapeutics (NASDAQ:QNCX) had its "market outperform" rating reaffirmed by analysts at Citigroup Inc..
Low
Report
Quince Therapeutics (NASDAQ:QNCX) had its "market outperform" rating reaffirmed by analysts at Citigroup Inc..
Date
Time
Symbol
Company Name
Action
%Chg
11/12/2025
04:05 pm
qncx
quince therapeutics, inc.
MISS
Report
-2.1%
quince therapeutics, inc.
8/11/2025
04:05 pm
qncx
quince therapeutics, inc.
MISS
Report
-1.3%
quince therapeutics, inc.
5/13/2025
08:00 am
qncx
quince therapeutics, inc.
MISS
Report
-7.8%
quince therapeutics, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
2/2
04:30 pm
qncx
Form 8-K Quince Therapeutics, For: Jan 30
High
Report
Form 8-K Quince Therapeutics, For: Jan 30
1/29
04:40 pm
qncx
Form 8-K Quince Therapeutics, For: Jan 29
High
Report
Form 8-K Quince Therapeutics, For: Jan 29
1/23
08:25 pm
qncx
Form 4 Quince Therapeutics, For: Jan 23 Filed by: Thye Dirk
Low
Report
Form 4 Quince Therapeutics, For: Jan 23 Filed by: Thye Dirk
1/23
08:07 pm
qncx
Form 4 Quince Therapeutics, For: Jan 23 Filed by: Ryan Charles S.
Low
Report
Form 4 Quince Therapeutics, For: Jan 23 Filed by: Ryan Charles S.
1/23
08:06 pm
qncx
Form 4 Quince Therapeutics, For: Jan 23 Filed by: Hannah Brendan
Low
Report
Form 4 Quince Therapeutics, For: Jan 23 Filed by: Hannah Brendan
1/21
06:14 pm
qncx
Form 4 Quince Therapeutics, For: Jan 02 Filed by: Senner Christopher J.
Low
Report
Form 4 Quince Therapeutics, For: Jan 02 Filed by: Senner Christopher J.
1/21
06:11 pm
qncx
Form 4 Quince Therapeutics, For: Jan 02 Filed by: McLoughlin Margaret
Low
Report
Form 4 Quince Therapeutics, For: Jan 02 Filed by: McLoughlin Margaret
1/21
06:05 pm
qncx
Form 4 Quince Therapeutics, For: Jan 02 Filed by: Lamond David
Low
Report
Form 4 Quince Therapeutics, For: Jan 02 Filed by: Lamond David
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: